BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15031195)

  • 1. Tetraspanin protein KAI1 expression in retinoblastoma.
    AmirthaLakshmi S; Pushparaj V; Krishnamurthy V; Biswas J; Krishnakumar S; Shanmugam MP
    Br J Ophthalmol; 2004 Apr; 88(4):593-5. PubMed ID: 15031195
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Fas ligand in retinoblastoma.
    Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
    Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
    Schwimer CJ; Prayson RA
    Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraosseous embryonal rhabdomyosarcoma as a second neoplasm following retinoblastoma.
    Hwang JC; Ko JY; Hsiao CC; Chen WJ; Huang CC
    Pathology; 2005 Dec; 37(6):552-4. PubMed ID: 16373234
    [No Abstract]   [Full Text] [Related]  

  • 7. [KAI1/CD82 and ME491/CD63 expression in non-small-cell carcinoma of the lung and prognosis].
    Adachi M; Taki T; Ieki Y; Ko S; Higashiyama S; Kodama K; Doi S; Miyake M
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):398-401. PubMed ID: 9235357
    [No Abstract]   [Full Text] [Related]  

  • 8. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
    Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
    Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
    Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
    Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAI1 tetraspanin and metastasis suppressor.
    Jackson P; Marreiros A; Russell PJ
    Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
    Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
    Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma in an adult: case report and literature review.
    Odashiro AN; Pereira PR; de Souza Filho JP; Cruess SR; Burnier MN
    Can J Ophthalmol; 2005 Apr; 40(2):188-91. PubMed ID: 16049534
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of KAI1/CD82 in human colorectal tumor.
    Wu DH; Liu L; Chen LH; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):714-5, 719. PubMed ID: 12865229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-CastaƱeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
    Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
    J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of S-100 protein immunoreactivity in normal human retina and retinoblastoma.
    Karim MM; Itoh H
    Ophthalmologica; 1997; 211(6):351-3. PubMed ID: 9380352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
    Indovina P; Acquaviva A; De Falco G; Rizzo V; Onnis A; Luzzi A; Giorgi F; Hadjistilianou T; Toti P; Tomei V; Pentimalli F; Carugi A; Giordano A
    J Cell Physiol; 2010 Apr; 223(1):143-50. PubMed ID: 20039270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAI1 gene expression in colonic carcinoma and its clinical significances.
    Wu DH; Liu L; Chen LH; Ding YQ
    World J Gastroenterol; 2004 Aug; 10(15):2245-9. PubMed ID: 15259074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
    Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.